6533b857fe1ef96bd12b5033

RESEARCH PRODUCT

International Consensus Group on Depression Prevention in Bipolar Disorder

Shigenobu KanbaMark A. FryeVieta EduardGustavo H. VázquezTadafumi KatoKyooseob HaAyşegül ÖZerdemSusan L. Mcelroy

subject

PsychiatryDepressive Disordermedicine.medical_specialtyBipolar DisorderTreatment outcomeGuidelines as TopicComorbidityNeuropsychiatrymedicine.diseaseAntidepressive AgentsPsychiatry and Mental healthTreatment OutcomeRecurrenceFamily medicinemedicineDepression preventionHumansDrug Therapy CombinationBipolar disorderPsychologyPsychiatry

description

The conference was chaired by Mark A. Frye, MD, Department of Psychiatry, The Mayo Clinic, Rochester, Minnesota, United States. The faculty were Kyooseob Ha, MD, PhD, Department of Psychiatry, Seoul National University Bundang Hospital, Seongnam, and the Department of Psychiatry and Behavioral Science, Seoul National University College of Medicine, Seoul, Republic of Korea; Shigenobu Kanba, MD, PhD, Department of Neuropsychiatry, University of Kyushu, Fukuoka-shi, Fukuoka, Japan; Tadafumi Kato, MD, PhD, Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Hirosawa, Wako, Saitama, Japan; Susan L. McElroy, MD, Department of Psychiatry and Behavioral Sciences, University of Cincinnati, and the Lindner Center of HOPE, Cincinnati, Ohio, United States; Aysegul Ozerdem, MD, PhD, Department of Psychiatry and the Department of Neuroscience, Dokuz Eylul University, Narlidere, Izmir, Turkey; Gustavo Vazquez, MD, PhD, Department of Neuroscience, University of Palermo, Buenos Aires, Argentina; and Eduard Vieta, MD, PhD, Bipolar Disorder Program and the Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.

https://doi.org/10.4088/jcp.10123co1c